/Investor DB

Function Ventures — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Galatea Biogalatea.bioAug 2024

Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.

HealthtechMiami Lakes, US

Carlos D. Bustamante(Executive Officer, Director)inArthur Polk(Executive Officer)Alexander Ioannidis(Director)

BoardWale Ayeni(Director)inMohit Kaushal(Director)Nicholas Katsanis(Director)

Co-investorsCEI VenturesCitta CapitalF-Prime CapitalFounder CollectiveHelios Digital VenturesLifeX Ventures+4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.